Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Upland Software
UPLD
$15.4M
| $436K | ﹤0.01% |
1,255
+493
| +65% | +$154K |
|
|
AAWW
3402
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $435K | ﹤0.01% |
10,100
-11,100
| -52% | -$390K |
|
|
AKRO
3403
DELISTED
Akero Therapeutics
AKRO
| $434K | ﹤0.01% |
17,399
+14,617
| +525% | +$334K |
|
3404
PUT
Brookfield
BN
$108B
| $434K | ﹤0.01% |
24,664
-12,612
| -34% | -$222K |
|
3405
Dorian LPG
LPG
$1.96B
| $434K | ﹤0.01% |
56,115
-18,407
| -25% | -$152K |
|
3406
ANI Pharmaceuticals
ANIP
$1.78B
| $433K | ﹤0.01% |
13,393
+916
| +7% | +$32.8K |
|
|
BBT
3407
Beacon Financial Corp
BBT
$2.66B
| $433K | ﹤0.01% |
39,445
+3,789
| +11% | +$48.7K |
|
3408
CALL
CF Industries
CF
$17.3B
| $433K | ﹤0.01% |
15,400
-56,000
| -78% | -$1.59M |
|
3409
Central Pacific Financial
CPF
$1B
| $433K | ﹤0.01% |
26,981
+4,261
| +19% | +$67.7K |
|
3410
PUT
iShares Russell 3000 ETF
IWV
$20.3B
| $432K | ﹤0.01% |
2,400
-900
| -27% | -$152K |
|
3411
Ericsson
ERIC
$33.3B
| $431K | ﹤0.01% |
46,335
-63,119
| -58% | -$548K |
|
3412
Pacific Biosciences
PACB
$368M
| $431K | ﹤0.01% |
124,930
+49,496
| +66% | +$169K |
|
|
TGI
3413
DELISTED
Triumph Group
TGI
| $431K | ﹤0.01% |
47,890
-101
| -0.2% | -$747 |
|
|
ABTX
3414
DELISTED
Allegiance Bancshares
ABTX
| $431K | ﹤0.01% |
16,964
+1,734
| +11% | +$42.5K |
|
3415
Evolent Health
EVH
$447M
| $430K | ﹤0.01% |
60,341
-310,168
| -84% | -$2.08M |
|
3416
PUT
Teva Pharmaceuticals
TEVA
$41.2B
| $430K | ﹤0.01% |
34,900
-755,500
| -96% | -$8.54M |
|
3417
Argan
AGX
$8.37B
| $429K | ﹤0.01% |
9,054
-34,168
| -79% | -$1.31M |
|
3418
CALL
S&P Global
SPGI
$120B
| $428K | ﹤0.01% |
1,300
-13,900
| -91% | -$4.18M |
|
3419
Vericel Corp
VCEL
$2.31B
| $427K | ﹤0.01% |
30,950
+12,135
| +64% | +$164K |
|
|
GLUU
3420
CALL
DELISTED
Glu Mobile Inc.
GLUU
| $427K | ﹤0.01% |
46,100
-27,600
| -37% | -$235K |
|
3421
Enterprise Financial Services Corp
EFSC
$2.39B
| $426K | ﹤0.01% |
13,682
+5,606
| +69% | +$163K |
|
3422
nVent Electric
NVT
$26.7B
| $426K | ﹤0.01% |
22,747
-76,741
| -77% | -$1.4M |
|
3423
Revolve Group
RVLV
$1.73B
| $426K | ﹤0.01% |
28,700
-22,273
| -44% | -$293K |
|
3424
Core Laboratories
CLB
$521M
| $425K | ﹤0.01% |
20,925
-52,051
| -71% | -$933K |
|
3425
Kosmos Energy
KOS
$1.48B
| $425K | ﹤0.01% |
255,655
+161,941
| +173% | +$260K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.